Combination Chemotherapy With or Without Trastuzumab in Treating Women With Breast Cancer (Q66036851)
Jump to navigation
Jump to search
clinical trial
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Combination Chemotherapy With or Without Trastuzumab in Treating Women With Breast Cancer |
clinical trial |
Statements
Multicenter Phase III Randomized Trial Comparing Doxorubicin and Cyclophosphamide Followed By Docetaxel (AC-T) With Doxorubicin and Cyclophosphamide Followed By Docetaxel and Trastuzumab (Herceptin)(AC-TH) and With Docetaxel, Carboplatin and Trastuzumab (TCH) In The Adjuvant Treatment Of Node Positive and High Risk Node Negative Patients With Operable Breast Cancer Containing The HER2 Alteration (English)
0 references
April 2001
0 references
December 2014
0 references
3,222
0 references
18 year
0 references
70 year
0 references